(2022) demonstrated that IL-1RII can also promote oncogenic signaling by activating the Janus kinase 2 (JAK2)/signal transducer and activator of transcription 3 (STAT3) pathway in clear cell renal cell carcinoma (ccRCC) (58, 59). This evidence concerns the gene JAK2 and nonpapillary renal cell carcinoma.